Eisai Co., Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -1.40%57.946.5%$171.20m
CTLTCatalent, Inc. 2.38%78.032.1%$130.10m
VRXValeant Pharmaceuticals International, Inc. -2.08%17.1914.1%$101.15m
JAZZJazz Pharmaceuticals Plc -2.16%105.222.4%$94.82m
BHCBausch Health Cos., Inc. -2.14%17.180.0%$71.88m
UTHRUnited Therapeutics Corp. -0.22%117.5214.3%$69.38m
ICPTIntercept Pharmaceuticals, Inc. -0.39%43.8816.8%$60.71m
PCRXPacira Biosciences, Inc. 1.72%57.5110.3%$52.80m
AXSMAxsome Therapeutics, Inc. -4.12%82.301.9%$51.76m
ZGNXZogenix, Inc. 0.46%28.417.5%$49.63m
PRGOPerrigo Co. Plc -1.88%53.906.8%$47.23m
MYOKMyoKardia, Inc. -2.57%92.841.8%$45.75m
ARGXargenx SE -0.12%251.080.0%$42.41m
GWPHGW Pharmaceuticals Plc -0.50%128.356.2%$39.11m
ICLRICON plc 1.56%174.074.3%$37.33m

Company Profile

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.